Blueprint Medicines · 2 hours ago
Senior Quality Assurance III
Blueprint Medicines is a company focused on advancing targeted therapies for patients with genomically defined cancers. They are seeking a Senior Quality Assurance III to manage product complaint handling and support Quality Systems & Compliance functions, including document control and regulatory inspection preparation.
BioinformaticsBiotechnologyHealth CareMedical
Responsibilities
Intake of Product Complaints from the Blueprint Medicines secured access mailbox
Perform weekly and monthly product complaint reconciliations with vendors, partners, affiliates and Drug Safety & Pharmacovigilance
Assist in providing product complaint metrics reports. Develop training on product complaint handling
Assist with revisions of product complaint SOPs/WI
Archive product complaints in accordance with Blueprint policies
Support document control with archival
Support regulatory inspection preparation and onsite during inspections as required
Support events and actions team with daily tasks/follow-ups
Qualification
Required
Prior Experience in management of product complaints and/or adverse event process, intake, reconciliations, etc
Experience with GxP regulations including but not limited to product complaint handling, patient privacy principles, document control, etc
B.S. Degree in life science, chemistry or engineering or equivalent and a minimum of 4 years' experience in Pharmaceutical Quality or Regulatory
Preferred
Experience with Veeva QualityDocs and Veeva eQMS a plus
Company
Blueprint Medicines
Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.
H1B Sponsorship
Blueprint Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (15)
2024 (10)
2023 (8)
2022 (22)
2021 (8)
2020 (11)
Funding
Current Stage
Public CompanyTotal Funding
$2.37BKey Investors
Partner Fund ManagementNextech InvestEight Roads Ventures
2025-06-02Acquired
2022-06-30Post Ipo Equity· $1.25B
2019-03-28Post Ipo Equity· $327.2M
Recent News
2026-01-22
2026-01-17
2026-01-03
Company data provided by crunchbase